Literature DB >> 12429410

Changes in sleep-waking cycle after striatal excitotoxic lesions.

Juan Mena-Segovia1, León Cintra, Oscar Prospéro-García, Magda Giordano.   

Abstract

Huntington's disease (HD) patients show severe diurnal choreic movements, while during slow-wave sleep (SWS) abnormal movements subside. Sleep disturbances in HD, including irregular delta activity and decreases in SWS, have also been reported. Striatal excitotoxic lesions have been shown to induce increased nocturnal spontaneous locomotor activity in rodents. In order to characterize the changes in circadian activity and sleep patterns and their correlation with motor activity after striatal excitotoxic lesions, Sprague-Dawley rats were implanted and lesioned; their locomotor and EEG activities were recorded for either 4 or 24 h during baseline or 7 and 30 days post-lesion. Locomotor activity increased significantly at 7 days post-lesion during the dark phase of the light-dark cycle. In contrast, total time spent in wakefulness (W) increased at 30 days post-lesion during the light phase of the cycle. This increase was at the expense of SWS duration. No disruption of the circadian curves was observed. Increases in the number of W-bouts and decreases in the duration of SWS-bouts were also observed. These results suggest the possible participation of the striatum in the regulation of the sleep-waking cycle, independent of locomotor activity. The increase in W could be due to loss of inhibition of target structures involved in regulation of the sleep-waking cycle. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429410     DOI: 10.1016/s0166-4328(02)00201-2

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  10 in total

1.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

Review 2.  How vital is sleep in Huntington's disease?

Authors:  Anna O G Goodman; Roger A Barker
Journal:  J Neurol       Date:  2010-03-24       Impact factor: 4.849

3.  Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire.

Authors:  Anna O G Goodman; A Jennifer Morton; Roger A Barker
Journal:  PLoS Curr       Date:  2010-10-15

4.  Basal ganglia control of sleep-wake behavior and cortical activation.

Authors:  Mei-Hong Qiu; Ramalingam Vetrivelan; Patrick M Fuller; Jun Lu
Journal:  Eur J Neurosci       Date:  2010-01-25       Impact factor: 3.386

5.  Microinjection of urotensin II into the pedunculopontine tegmentum leads to an increase in the consumption of sweet tastants.

Authors:  Robert Ettaro; Tamara Markovic; Derek Daniels; Duncan Aa MacLaren; Stewart D Clark
Journal:  Physiol Behav       Date:  2019-12-13

6.  Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease.

Authors:  Anna O G Goodman; Lorraine Rogers; Samantha Pilsworth; Catherine J McAllister; John M Shneerson; A Jennifer Morton; Roger A Barker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

7.  The sleep and circadian problems of Huntington's disease: when, why and their importance.

Authors:  Z Voysey; S V Fazal; A S Lazar; R A Barker
Journal:  J Neurol       Date:  2020-12-23       Impact factor: 4.849

Review 8.  The Pedunculopontine Tegmental Nucleus as a Motor and Cognitive Interface between the Cerebellum and Basal Ganglia.

Authors:  Fumika Mori; Ken-Ichi Okada; Taishin Nomura; Yasushi Kobayashi
Journal:  Front Neuroanat       Date:  2016-11-07       Impact factor: 3.856

Review 9.  The subcortical belly of sleep: New possibilities in neuromodulation of basal ganglia?

Authors:  Harutomo Hasegawa; Richard Selway; Valentina Gnoni; Sandor Beniczky; Steve C R Williams; Meir Kryger; Luigi Ferini-Strambi; Peter Goadsby; Guy D Leschziner; Keyoumars Ashkan; Ivana Rosenzweig
Journal:  Sleep Med Rev       Date:  2020-04-22       Impact factor: 11.609

10.  Striatal adenosine A2A receptor neurons control active-period sleep via parvalbumin neurons in external globus pallidus.

Authors:  Xiang-Shan Yuan; Lu Wang; Hui Dong; Wei-Min Qu; Su-Rong Yang; Yoan Cherasse; Michael Lazarus; Serge N Schiffmann; Alban de Kerchove d'Exaerde; Rui-Xi Li; Zhi-Li Huang
Journal:  Elife       Date:  2017-10-12       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.